Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | PNMT | P11086 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | IDO1 | P14902 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.40 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.40 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL31129160 | 0.98 | CYP3A4 (0.50) | CYP3A4CYP2A6TAAR1ALDH1A1PNMT | |
| SCHEMBL9479134 | 0.84 | CYP3A4 (0.45) | CYP3A4CYP2A6ALDH1A1PNMTMAPT | |
| SCHEMBL13846496 | 0.83 | TAAR1 (0.64) | CYP3A4TAAR1ALDH1A1MAPTIDO1 | |
| SCHEMBL193074 | 0.82 | CYP3A4 (0.46) | CYP3A4CYP2A6ALDH1A1PNMTIDO1 | |
| SCHEMBL6588336 | 0.82 | CYP3A4 (0.46) | CYP3A4CYP2A6ALDH1A1MAPTIDO1 | |
| Hydrochloric Acid SCHEMBL17330388 | 0.81 | TAAR1 (0.62) | CYP3A4TAAR1ALDH1A1MAPTIDO1 | |
| SCHEMBL31459834 | 0.79 | CYP3A4 (0.48) | CYP3A4CYP2A6ALDH1A1MAPTIDO1 | |
| SCHEMBL9861809 | 0.79 | CYP3A4 (0.48) | CYP3A4CYP2A6ALDH1A1MAPTIDO1 | |
| SCHEMBL8418306 | 0.79 | CYP3A4 (0.48) | CYP3A4TAAR1ALDH1A1MAPTIDO1 | |
| SCHEMBL701343 | 0.78 | CYP2A6 (0.48) | CYP3A4CYP2A6TAAR1ALDH1A1PNMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 189 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118702581-A | Efficient separation method of 3-chloro-2-methylaniline and 5-chloro-2-methylaniline | 上海鲲博玖瑞医药科技发展有限公司 | 2024-09-27 | — | — | CN | claimed |
| EP-2906559-B1 | AZAINDOLINES | HOFFMANN LA ROCHE (CH) | 2017-02-08 | — | — | EP | claimed |
| EP-1831206-B1 | N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY | OSI PHARM INC (US) | 2011-08-24 | — | — | EP | claimed |
| EP-1610779-B1 | 3-OXO-1,3-DIHYDRO-INDAZOLE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AS PHOSPHOLIPASE INHIBITORS | LILLY CO ELI (US) | 2009-09-09 | — | — | EP | claimed |
| JP-2008521903-A | — | — | 2008-06-26 | — | — | JP | claimed |
| EP-1831206-A2 | N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY | OSI Pharmaceuticals, Inc. (US) | 2007-09-12 | — | — | EP | claimed |
| WO-2006060381-A2 | N-SUBSTITUTED BENZIMIDAZOLYL C-KIT INHIBITORS AND COMBINATORIAL BENZIMIDAZOLE LIBRARY | OSI PHARMACEUTICALS, INC. (US) | 2006-06-08 | — | — | WO | claimed |
| US-20060116402-A1 | N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library | OSI PHARMACEUTICALS, INC. | 2006-06-01 | — | — | US | claimed |
| CN-117105800-B | Pendimethalin hapten, pendimethalin antigen, pendimethalin antibody and preparation method and application of pendimethalin hapten, pendimethalin antigen and pendimethalin antibody | 贵州国芯生物科技有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-118702581-A | Efficient separation method of 3-chloro-2-methylaniline and 5-chloro-2-methylaniline | 上海鲲博玖瑞医药科技发展有限公司 | 2024-09-27 | — | — | CN | disclosed |
| CN-117105800-A | Pendimethalin hapten, pendimethalin antigen, pendimethalin antibody and preparation method and application of pendimethalin hapten, pendimethalin antigen and pendimethalin antibody | 贵州国芯生物科技有限公司 | 2023-11-24 | — | — | CN | disclosed |
| US-20230364032-A1 | USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS | VANDERBILT UNIVERSITY | 2023-11-16 | — | — | US | disclosed |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | VANDERBILT UNIVERSITY | 2023-11-09 | — | — | US | disclosed |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | MTI BIOTECH, INC. | 2023-10-19 | — | — | US | disclosed |
| US-6515011-B2 | Anticoagulants | MERCK & CO., INC. | 2003-02-04 | — | — | US | disclosed |
| EP-1259506-A1 | PYRAZINONE THROMBIN INHIBITORS | Merck & Co., Inc. (US) | 2002-11-27 | — | — | EP | disclosed |
| US-20020119992-A1 | Thrombin inhibitors | MERCK & CO., INC. | 2002-08-29 | — | — | US | disclosed |
| WO-2002050056-A1 | BENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | MERCK & CO., INC. (US) | 2002-06-27 | — | — | WO | disclosed |
| US-6387911-B1 | Pyrazinone thrombin inhibitors | MERCK & CO., INC. | 2002-05-14 | — | — | US | disclosed |
| WO-2001038323-A1 | PYRAZINONE THROMBIN INHIBITORS | MERCK & CO., INC. (US) | 2001-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020119992-A1 | Thrombin inhibitors | SERPINC1, F2, TFPI | CYP3A4 1979/4885CYP2A6 3469/4885TAAR1 3437/4885 |
| US-20230364032-A1 | USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS | HACL2, APOB, OAT | CYP3A4 4366/4885CYP2A6 2047/4885TAAR1 3700/4885 |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | FABP2, SI, MLN | CYP3A4 3794/4885CYP2A6 2656/4885TAAR1 4642/4885 |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | GGT1, GGH, AKR7A2 | CYP3A4 2680/4885CYP2A6 1473/4885TAAR1 1641/4885 |
| US-20060116402-A1 | N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole library | KIT, CHUK, TNNI3K | CYP3A4 3141/4885CYP2A6 4453/4885TAAR1 4483/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.